166 related articles for article (PubMed ID: 32869113)
1. Risk factors for pancreas and lung neuroendocrine neoplasms: a case-control study.
Giraldi L; Vecchioni A; Carioli G; Bilotta M; La Rosa S; Imperatori A; Volante M; Brizzi MP; Inzani F; Petrone G; Schinzari G; Bianchi A; Margaritora S; Alfieri S; La Vecchia C; Boccia S; Rindi G
Endocrine; 2021 Jan; 71(1):233-241. PubMed ID: 32869113
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysis.
Leoncini E; Carioli G; La Vecchia C; Boccia S; Rindi G
Ann Oncol; 2016 Jan; 27(1):68-81. PubMed ID: 26487581
[TBL] [Abstract][Full Text] [Related]
3. Risk factors associated with neuroendocrine tumors: A U.S.-based case-control study.
Hassan MM; Phan A; Li D; Dagohoy CG; Leary C; Yao JC
Int J Cancer; 2008 Aug; 123(4):867-73. PubMed ID: 18491401
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine neoplasms of lung, pancreas and gut: a morphology-based comparison.
Kasajima A; Klöppel G
Endocr Relat Cancer; 2020 Nov; 27(11):R417-R432. PubMed ID: 33032264
[TBL] [Abstract][Full Text] [Related]
5. Identification of sequence polymorphisms in the displacement loop region of mitochondrial DNA as a risk factor for gastroenteropancreatic neuroendocrine neoplasm.
Er LM; Wu ML; Gao Y; Wang SJ; Li Y
J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27704598
[TBL] [Abstract][Full Text] [Related]
6. How should incidental NEN of the pancreas and gastrointestinal tract be followed?
Ariotti R; Partelli S; Muffatti F; Andreasi V; Della Sala F; Falconi M
Rev Endocr Metab Disord; 2018 Jun; 19(2):139-144. PubMed ID: 29527619
[TBL] [Abstract][Full Text] [Related]
7. Diabetes, smoking, alcohol use, and family history of cancer as risk factors for pancreatic neuroendocrine tumors: a systematic review and meta-analysis.
Haugvik SP; Hedenström P; Korsæth E; Valente R; Hayes A; Siuka D; Maisonneuve P; Gladhaug IP; Lindkvist B; Capurso G
Neuroendocrinology; 2015; 101(2):133-42. PubMed ID: 25613442
[TBL] [Abstract][Full Text] [Related]
8. Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study.
Masui T; Ito T; Komoto I; Uemoto S;
BMC Cancer; 2020 Nov; 20(1):1104. PubMed ID: 33189127
[TBL] [Abstract][Full Text] [Related]
9. Gastroenteropancreatic neuroendocrine neoplasms: a 10-year experience of a single center.
Lewkowicz E; Trofimiuk-Müldner M; Wysocka K; Pach D; Kiełtyka A; Stefańska A; Sowa-Staszczak A; Tomaszewska R; Hubalewska-Dydejczyk A
Pol Arch Med Wewn; 2015; 125(5):337-46. PubMed ID: 25924181
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of primary site and pathology on 903 patients with neuroendocrine neoplasms].
Qiu X; Liu M; Liu Q; Yang Z; Liu J; Meng F; Wang Z; Shi Y; Liu L; Zhang P; Luo J; Tan H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):993-996. PubMed ID: 28900988
[TBL] [Abstract][Full Text] [Related]
11. The Risk of Second Primary Colorectal Adenocarcinomas Is Not Increased among Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Nationwide Population-Based Study.
Stemann Lau T; Dam G; Jepsen P; Grønbæk H; Krogh K; Gregersen T
Neuroendocrinology; 2018; 107(3):280-283. PubMed ID: 30092588
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological Data and Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms: Insights From Tertiary Referral Hospitals in Latvia.
Ptasnuka M; Ozolins A; Narbuts Z; Truskovs A; Sperga M; Plaudis H
World J Surg; 2020 Feb; 44(2):585-593. PubMed ID: 31605174
[TBL] [Abstract][Full Text] [Related]
13. Risk and protective factors for the occurrence of sporadic pancreatic endocrine neoplasms.
Valente R; Hayes AJ; Haugvik SP; Hedenström P; Siuka D; Korsæth E; Kämmerer D; Robinson SM; Maisonneuve P; Delle Fave G; Lindkvist B; Capurso G
Endocr Relat Cancer; 2017 Aug; 24(8):405-414. PubMed ID: 28566532
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of Neuroendocrine Tumors.
Fraenkel M; Faggiano A; Valk GD
Front Horm Res; 2015; 44():1-23. PubMed ID: 26303701
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis of pancreatic neuroendocrine tumor led to diagnosis of multiple endocrine neoplasia type 1:a report of two cases].
Toriyama K; Hijioka S; Oseto K; Mizuno N; Tanaka T; Ishihara M; Tajika M; Shimizu Y; Hara K; Niwa Y
Nihon Shokakibyo Gakkai Zasshi; 2019; 116(6):531-539. PubMed ID: 31178583
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors of gastrointestinal neuroendocrine neoplasm metastasis in liver, lung, bone, and brain: A population-based study.
Zheng Z; Chen C; Jiang L; Zhou X; Dai X; Song Y; Li Y
Cancer Med; 2019 Dec; 8(17):7288-7298. PubMed ID: 31609098
[TBL] [Abstract][Full Text] [Related]
17. Substance use and esophageal neuroendocrine neoplasm: A case-control study.
Wang YK; Shih HY; Chu YY; Kuo CH; Chen YH; Chung CS; Tsai CL; Lin JC; Wang HP; Wu IC
Kaohsiung J Med Sci; 2022 Dec; 38(12):1224-1229. PubMed ID: 36156405
[TBL] [Abstract][Full Text] [Related]
18. Sex Differences in Survival from Neuroendocrine Neoplasia in England 2012-2018: A Retrospective, Population-Based Study.
White BE; Russell B; Remmers S; Rous B; Chandrakumaran K; Wong KF; Van Hemelrijck M; Srirajaskanthan R; Ramage JK
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980749
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors: A Case-Control Study.
Ben Q; Zhong J; Fei J; Chen H; Yv L; Tan J; Yuan Y
Sci Rep; 2016 Oct; 6():36073. PubMed ID: 27782199
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of OTP and NKX6.1 in neuroendocrine tumors of the lung and pancreas.
Yoxtheimer LM; Heymann JJ; Cohen C; Rao RA; Goyal A; Siddiqui MT
Diagn Cytopathol; 2018 Dec; 46(12):1010-1014. PubMed ID: 30284410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
